Virios Therapeutics, Inc.

VIRI

VIRIVirios Therapeutics, Inc. US flag

NASDAQ Capital Market

0.16

USD

+0.02

- -

206,502.00Market Cap

Income Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	2	2	10	16	12	5
+ Selling, General & Admin	1	1	10	5	4	4
+ Research & Development	1	1	- -	11	8	2
+ Other Operating Expense	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-2	-2	-10	-16	-12	-5
- Non-Operating (Income) Loss	- -	- -	- -	- -	- -	- -
+ Interest Expense, Net	- -	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	- -	- -
Pretax Income	-2	-2	-10	-16	-12	-5
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-2	-10	-16	-12	-5
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-2	-2	-10	-16	-12	-5
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-2	-2	-10	-16	-12	-5
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-2	-10	-16	-12	-5
EBIT	-2	-2	-10	-16	-12	-5
EBITDA	-2	-2	-10	-16	-12	-5
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
EBITA	-2	-2	-10	-16	-12	-5
Gross Margin (%)	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1
Basic EPS, GAAP	-10.93	-12.8	-52.5	-47.9	-27.66	-7.05
Basic EPS from Cont Ops	-10.93	-12.8	-52.5	-47.9	-27.66	-7.05
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1
Diluted EPS, GAAP	-10.93	-12.8	-52.5	-47.9	-27.66	-7.05
Diluted EPS from Cont Ops	-10.93	-12.8	-52.5	-47.9	-27.66	-7.05

Balance Sheet (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	- -	- -	31	16	8	4
+ Cash, Cash Equivalents & STI	- -	- -	30	14	7	3
+ Cash & Cash Equivalents	- -	- -	30	14	7	3
+ ST Investments	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	2	2	1	1
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -	- -
Total Assets	- -	- -	31	16	8	4
+ Payables & Accruals	1	2	1	1	1	- -
+ Accounts Payable	- -	- -	- -	- -	1	- -
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	1	2	1	- -	- -	- -
+ ST Debt	- -	- -	- -	- -	- -	- -
+ ST Borrowings	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	1	1	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	1	1	- -	- -
Total Current Liabilities	1	2	2	1	1	- -
+ LT Debt	- -	4	- -	- -	- -	- -
+ LT Borrowings	- -	4	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	- -	4	- -	- -	- -	- -
Total Liabilities	1	5	2	1	1	- -
+ Preferred Equity and Hybrid Capital	1	- -	- -	- -	- -	- -
+ Share Capital & APIC	13	13	58	58	63	66
+ Common Stock	13	13	- -	- -	- -	- -
+ Additional Paid in Capital	- -	- -	58	58	63	66
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-15	-18	-28	-44	-56	-61
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-1	-5	30	15	7	4
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	-1	-5	30	15	7	4
Total Liabilities & Equity	- -	- -	31	16	8	4
Shares Outstanding	- -	- -	- -	- -	1	1
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -	- -
Net Debt	- -	3	-30	-14	-7	-3
Net Debt to Equity	2.38	-67.34	-99.51	-96.6	-95.97	-87.13
Tangible Common Equity Ratio	-3,858.17	-1,588.32	95.13	91.91	87.54	91.39
Current Ratio	0.03	0.19	20.55	12.37	8.02	11.62
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-2	-2	-10	-16	-12	-5
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -
+ Non-Cash Items	- -	- -	7	- -	1	1
+ Stock-Based Compensation	- -	- -	7	- -	1	1
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -	- -	- -
+ Chg in Non-Cash Work Cap	1	- -	-1	- -	- -	- -
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-2	- -	- -	- -
+ Inc (Dec) in Accts Payable	1	- -	1	- -	- -	-1
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-1	-2	-4	-16	-11	-5
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	31	- -	4	1
+ Increase in Capital Stock	- -	- -	31	- -	4	1
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	- -	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	2	2	- -	- -	- -
+ Cash From Debt	- -	2	2	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	1	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	1	2	33	- -	4	1
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	- -	- -	29	-16	-7	-4
EBITDA	-2	-2	-10	-16	-12	-5
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -
Free Cash Flow	-1	-2	-4	-16	-11	-5
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-1	-2	-16	-11	-5
Free Cash Flow per Basic Share	-6.19	-10.82	-19.76	-47.09	-25.9	-6.48
Price/Free Cash Flow	- -	- -	-9.5	-2.72	-0.23	-2.22
Cash Flow to Net Income	0.57	0.85	0.38	0.98	0.94	0.92
Capital Expenditures	- -	- -	- -	- -	- -	- -